What is BioSig Technologies, Inc.'s D&A?

BioSig Technologies, Inc. (STEX) reported D&A of $1.49M in Q1 2026.

How has BioSig Technologies, Inc.'s D&A changed year-over-year?

BioSig Technologies, Inc.'s D&A increased by 7004.8% year-over-year, from $21K to $1.49M.

What is the long-term trend for BioSig Technologies, Inc.'s D&A?

Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s D&A has grown at a 105.5% compound annual growth rate (CAGR), from $198K to $3.53M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

BioSig Technologies, Inc. STEX D&A

D&A at other companies

Tradeweb Markets Inc.TW

$60.71M-3.2%

Bit DigitalBTBT

$10.04M+38.6%

Scilex Holding CompanySCLX

$2.09M+109%

StoneX Group Inc.SNEX

$26.9M+72.4%

MedtronicMDT

$716M-14.8%

GE HealthCare TechnologiesGEHC

——

Segments

By segment

See full

Corporate$1.49M+7,005%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-61.8%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s D&A?: BioSig Technologies, Inc. (STEX) reported D&A of $1.49M in Q1 2026.
How has BioSig Technologies, Inc.'s D&A changed year-over-year?: BioSig Technologies, Inc.'s D&A increased by 7004.8% year-over-year, from $21K to $1.49M.
What is the long-term trend for BioSig Technologies, Inc.'s D&A?: Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s D&A has grown at a 105.5% compound annual growth rate (CAGR), from $198K to $3.53M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.